Cardiac Imaging

The cardiac imaging channel includes the modalities of computed tomography (CT), cardiac ultrasound (echocardiography), magnetic resonance imaging (MRI), nuclear imaging (PET and SPECT), and angiography. 

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | January 23, 2019

The American College of Cardiology (ACC) released a list of the...

ASE Releases New Guide to Performing Comprehensive Transthoracic Echo Exams
News | Cardiovascular Ultrasound | January 21, 2019

January 21, 2019 – Medical experts have released “...

This is 3-D blood flow view of blood flow through the chambers of a fetal heart using the GE Healthcare fetalHQ analysis software. #RSNA18 #RSNA #RSNA2018

This is a 3-D view of blood flow through the chambers of a fetal heart using the GE Healthcare fetalHQ analysis software.

Feature | RSNA | January 17, 2019 | Dave Fornell, Editor

Many of the latest advances in cardiovascular imaging technologies are unveiled each year at the...

Philips Launches Azurion With FlexArm
Technology | Angiography | January 17, 2019

January 17, 2019 — Philips announced the launch of Azurion with FlexArm, designed to enhance positioning flexibility...

Artificial Intelligence in medical imaging was the top trend and buzz at RSNA 2018.

Artificial intelligence in medical imaging was the major buzz at RSNA 2018. The expo floor had a dedicated area just to highlight artificial intelligence software for medical imaging. More than 150 vendors on the expo floor were showing software using some level of AI or deep learning. 

Feature | Artificial Intelligence | January 17, 2019 | Dave Fornell, Editor

Artificial intelligence (AI) was by far the hottest trend discussed in sessions and across the expo floor at the...

NewYork-Presbyterian Hospital Partners With Philips for Health IT and Clinical Informatics
News | Cardiac PACS | January 16, 2019

January 16, 2019 – Philips announced that NewYork-Presbyterian Hospital has chosen to implement the company’s...

A MitraClip case underway at the University of Colorado Hospital hybrid cath lab. Left to right are doctors John Carroll, Edward Gill and Dominik Wiktor.

A MitraClip case underway at the University of Colorado Hospital hybrid cath lab. Left to right are doctors John Carroll, Edward Gill and Dominik Wiktor. 

Blog | University of Colorado Hospital | January 16, 2019

In late December, I had the opportunity to conduct an onsite visit to the...

The startup company Genetesis introduced a new cardiac imaging modalityit calls magnetocardiography. The scanner creates images from the biomagnetic activity of the heart, using the polarization and depolarization of the heart during the cardiac cycle. This was at AHA.18, AHA 2018 - the American Heart Association annual meeting

The startup company Genetesis introduced a new cardiac imaging modality it calls magnetocardiography. The scanner creates images from the biomagnetic activity of the heart, using the polarization and depolarization of the heart during the cardiac cycle.

Feature | AHA | January 14, 2019 | Dave Fornell, Editor

Here are a few of the takeaways from the clinical studies presented and new technology shown on the exhibit floor at...

Triton College Launching Vascular Technology in Sonography Certificate Program
News | Ultrasound Imaging | January 09, 2019

January 9, 2019 — Starting in spring 2019, Triton College’s...

SCCT Releases New Guideline for CT Use During TAVR
News | Computed Tomography (CT) | January 08, 2019

January 8, 2019 — The Society of Cardiovascular Computed Tomography (SCCT) has released...

The 2018 Most Popular Cardiology Topics - FDA approval of Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), and new pacemaker technologies.

The top two articles on DAIC from 2018 included the FDA approval of Andexxa, the first antidote indicated for patients treated with the anticoagulants rivaroxaban (Xarelto) and apixaban (Eliquis), and an article on new pacemaker technologies. 

Feature | January 04, 2019 | Dave Fornell, Editor

January 4, 2018 — Here is the top cardiology content on the Diagnostic and Interventional Cardiology (DAIC) website...

Overlay Init